Profile | GDS4284 / 200844_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 8335.76 | 96 |
GSM687648 | Patient 402 control | 8405.1 | 96 |
GSM687653 | Patient 403 control | 5404.12 | 94 |
GSM687658 | Patient 404 control | 5316.34 | 94 |
GSM687663 | Patient 411 control | 8783.52 | 97 |
GSM687668 | Patient 422 control | 8811.48 | 97 |
GSM687673 | Patient 424 control | 15609.6 | 98 |
GSM687678 | Patient 425 control | 6695.63 | 95 |
GSM687683 | Patient 427 control | 8607.16 | 97 |
GSM687688 | Patient 428 control | 6189.8 | 95 |
GSM687695 | Patient 441 control | 46363.5 | 99 |
GSM687699 | Patient 443 control | 5396.1 | 94 |
GSM687704 | Patient 444 control | 6074.22 | 95 |
GSM687707 | Patient 448 control | 7061.64 | 96 |
GSM687712 | Patient 449 control | 12042.4 | 98 |
GSM687719 | Patient 450 control | 11933.9 | 98 |
GSM687724 | Patient 451 control | 11380.4 | 97 |
GSM687728 | Patient 452 control | 11108.1 | 97 |
GSM687646 | Patient 401 treated 24h | 7129.97 | 96 |
GSM687649 | Patient 402 treated 24h | 7588.49 | 96 |
GSM687665 | Patient 411 treated 24h | 9138.2 | 97 |
GSM687651 | Patient 402 treated 4 weeks | 7622.62 | 96 |
GSM687667 | Patient 411 treated 4 weeks | 5731.74 | 94 |
GSM687670 | Patient 422 treated 24h | 8607.13 | 97 |
GSM687671 | Patient 422 treated 4 weeks | 8458.15 | 96 |
GSM687654 | Patient 403 treated 24h | 6422.77 | 95 |
GSM687675 | Patient 424 treated 24h | 17281.8 | 98 |
GSM687685 | Patient 427 treated 24h | 9951.5 | 97 |
GSM687656 | Patient 403 treated 4 weeks | 5955.12 | 94 |
GSM687677 | Patient 424 treated 4 weeks | 9237.48 | 97 |
GSM687687 | Patient 427 treated 4 weeks | 5181.47 | 94 |
GSM687692 | Patient 428 treated 4h | 4832.66 | 93 |
GSM687716 | Patient 449 treated 4h | 9397.36 | 97 |
GSM687722 | Patient 450 treated 4h | 12725.3 | 98 |
GSM687680 | Patient 425 treated 24h | 7274.86 | 96 |
GSM687690 | Patient 428 treated 24h | 5119.81 | 93 |
GSM687700 | Patient 443 treated 24h | 11903.4 | 98 |
GSM687705 | Patient 444 treated 24h | 7663.3 | 96 |
GSM687714 | Patient 449 treated 24h | 13596.7 | 98 |
GSM687721 | Patient 450 treated 24h | 25340.7 | 99 |
GSM687682 | Patient 425 treated 4 weeks | 6500.18 | 95 |
GSM687694 | Patient 428 treated 4 weeks | 6711.21 | 95 |
GSM687702 | Patient 443 treated 4 weeks | 5925.84 | 95 |
GSM687718 | Patient 449 treated 4 weeks | 9549.3 | 97 |
GSM687723 | Patient 450 treated 4 weeks | 9271.25 | 97 |
GSM687661 | Patient 404 treated 4h | 5473.7 | 94 |
GSM687710 | Patient 448 treated 4h | 9162.78 | 97 |
GSM687726 | Patient 451 treated 4h | 13166.3 | 98 |
GSM687730 | Patient 452 treated 4h | 23085.6 | 99 |
GSM687660 | Patient 404 treated 24h | 14996.8 | 98 |
GSM687697 | Patient 441 treated 24h | 20028.8 | 99 |
GSM687709 | Patient 448 treated 24h | 8580.35 | 96 |
GSM687725 | Patient 451 treated 24h | 14793.9 | 98 |
GSM687729 | Patient 452 treated 24h | 32351.1 | 99 |
GSM687727 | Patient 451 treated 4 weeks | 7101.26 | 96 |
GSM687731 | Patient 452 treated 4 weeks | 9583.17 | 97 |